Multi‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming
Open accessPublished version of a preprint
Abstract
The expression of the pluripotency factors OCT4, SOX2, KLF4, and MYC (OSKM) can convert somatic differentiated cells into pluripotent stem cells in a process known as reprogramming. Notably, partial and reversible reprogramming does not change cell identity but can reverse markers of aging in cells, improve the capacity of aged mice to repair tissue injuries, and extend longevity in progeroid mice. However, little is known about the mechanisms involved. Here, we have studied changes in the DNA methylome, transcriptome, and metabolome in naturally aged mice subject to a single period of transient OSKM expression. We found that this is sufficient to reverse DNA methylation changes that occur upon aging in the pancreas, liver, spleen, and blood. Similarly, we observed reversion of transcriptional changes, especially regarding biological processes known to change during aging. Finally, some serum metabolites and biomarkers altered with aging were also restored to young levels upon transient reprogramming. These observations indicate that a single period of OSKM expression can drive epigenetic, transcriptomic, and metabolomic changes toward a younger configuration in multiple tissues and in the serum.
AI snapshot
Written from the paper’s full text.
TL;DR
A single one-week cycle of transient OSKM expression in naturally aged mice partially reversed aging-associated DNA methylation, transcriptomic, and serum metabolomic changes across pancreas, liver, spleen, and blood. The effects were strongest in pancreas, detectable in tissues with low OSKM expression, and did not clearly reduce senescence markers.
Key findings
- In pancreas, RRBS identified 93 aging-differentially methylated promoters and 75 enhancers; 61 (36%) were reversed toward a younger state by OSKM. Pyrosequencing validated rejuvenation in 8 of 11 tested regions.
- Pancreatic RNAseq found 217 aging-differentially expressed genes; PCA placed old-OSKM samples between old and young. A gaga pattern analysis identified 179 rejuvenated gene-sets versus 44 after sample randomization, including mTOR, DNA replication/repair, proteostasis, and collagen-related sets.
- In liver, 61% of 108 combined aging-DM promoters/enhancers showed rejuvenation; five Mouse Aging Cell Atlas genes and Nrf2/ApoM returned to young levels, and serum AST/GOT and ALT/GPT were significantly lower after OSKM plus recovery.
- In blood, Hsf4 methylation rose from ~20% in young (~10 weeks) to ~55% in very old (~100 weeks); over 5 weeks, controls increased ~4% while reprogrammable mice decreased ~4%, an 8% difference. Serum metabolomics found 23 aging-associated metabolites, of which 4 were reversed: 4-hydroxyproline, thymine, trimethyl-lysine, and indole-3-propionic acid.
Methods
- Reprogrammable i4F-B mice carrying a doxycycline-inducible OSKM transgene were treated with 0.2 mg/ml doxycycline in drinking water for 7 days; ages included young (13 weeks), old (55 weeks), and very old (~100 weeks), with 2- or 4-week recovery periods.
- Multi-omic profiling used MspI-based RRBS for DNA methylation in pancreas, liver, and spleen; RNAseq and qRT-PCR for transcriptomes; bisulfite pyrosequencing for validation; and mass spectrometry-based serum metabolomics.
- Analyses included PCA, logistic regression for differential methylation, ROAST/GSEA-style enrichment, gaga Normal-Normal pattern analysis, and linear mixed models for metabolomics.
Limitations
- Stated: the study could not associate specific aging-DM regions with mRNA levels of nearby genes; OSKM may have non-cell-autonomous effects and changes in cell composition were not addressed; a single cycle may not rejuvenate senescent cells in aged liver; some OSKM-induced changes may be unstable and lost during recovery.
- Stated: very old mice were allocated by genotype rather than randomized; liver and spleen express OSKM weakly, and their epigenetic rejuvenation was less pronounced than in pancreas.
- Evident from the text: sample sizes were small (often n = 3–7 per group), and some conclusions rely on trends or partial separation in PCA rather than uniformly significant region-level changes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 59 cited sources checked · 0 supported · 0 flagged
- Findingown data
A single period of transient OSKM expression in naturally aged mice is sufficient to reverse DNA methylation changes that occur upon aging in the pancreas, liver, spleen, and blood.
“We found that this is sufficient to reverse DNA methylation changes that occur upon aging in the pancreas, liver, spleen, and blood.”
Quote in the paperSubstantial claim - Findingown data
DM enhancer at Chr10:68231400-68232600 showed a trend to be demethylated after OSKM activation.
“For example, DM enhancer at Chr10: 68231400–68232600 showed a trend to be demethylated after OSKM activation (Figure 1d).”
Quote in the paperNot a substantial claim - Findingown data
No remethylation was detected in these two positions after transient OSKM activation.
“However, we could not detect remethylation in these two positions after transient OSKM activation (Figure S1n).”
Quote in the paperNot a substantial claim - Findingown data
PCA showed that aging-DM enhancers in OSKM mice were distinct from old mice and displaced toward the young group.
“As before, PCA analysis showed that aging‐DM enhancers in OSKM mice were distinct from old mice and displaced toward the young group (Figure 1c).”
Quote in the paperSubstantial claim - Findingown data
Transient OSKM expression in naturally aged mice reverts transcriptional changes, especially regarding biological processes known to change during aging.
“Similarly, we observed reversion of transcriptional changes, especially regarding biological processes known to change during aging.”
Quote in the paperSubstantial claim
- Findingown data
Out of nine CpGs expected to gain methylation with aging, eight showed the expected increase in methylation with aging, specifically near genes Tpt1 (2 close CpGs), Stambpl1, Dnmbp (2 consecutive CpGs), Akt1, Gm12339, and Gm17678.
“Out of them, eight showed the expected increase in methylation with aging, specifically, those near genes Tpt1 (2 close CpGs), Stambpl1, Dnmbp (2 consecutive CpGs), Akt1, Gm12339, and Gm17678.”
Quote in the paperNot a substantial claim - Findingown data
The methylation profile of old-OSKM mice was placed by PCA between the young and old groups, revealing partial epigenetic rejuvenation of aging-sensitive promoters.
“Interestingly, the methylation profile of old‐OSKM mice was placed by PCA between the young and old groups, revealing partial epigenetic rejuvenation of aging‐sensitive promoters (Figure 1a).”
Quote in the paperSubstantial claim - Findingown data
Pyrosequencing confirmed that two aging-hypomethylated CpGs (1700011F14Rik and Ptprj) were hypomethylated with aging.
“We also tested two aging‐hypomethylated CpGs (1700011F14Rik and Ptprj) and pyrosequencing confirmed that both were hypomethylated with aging.”
Quote in the paperNot a substantial claim - Findingown data
Histological changes observed in the pancreas after one week of OSKM induction are reversed two weeks after removal of doxycycline.
“Importantly, the histological changes observed in the pancreas after one week of OSKM induction were reversed two weeks after removal of doxycycline (Figure S1a).”
Quote in the paperSubstantial claim - Findingown data
All eight regions presented reduced methylation in very old-OSKM mice treated with doxycycline, in some cases becoming indistinguishable from young mice.
“Interestingly, all eight regions presented reduced methylation in very old‐OSKM mice treated with doxycycline, in some cases becoming indistinguishable from young mice (Figure 1g, Figure S1l).”
Quote in the paperSubstantial claim - Findingown data
Reversion of methylation was consistently more profound after 4 weeks of recovery than after 2 weeks of recovery.
“Of note, reversion of methylation was consistently more profound after 4 weeks of recovery than after 2 weeks of recovery.”
Quote in the paperSubstantial claim - Findingown data
By comparing old and young pancreata, a list of differentially methylated (DM) promoters was identified.
“By comparing old and young groups, we identified a list of differentially methylated (DM) promoters (Figure S1f).”
Quote in the paperSubstantial claim - Findingown data
Detection of pluripotency markers in pancreas requires two weeks of OSKM expression.
“Of note, the detection of pluripotency markers in pancreas required two weeks of OSKM expression (Figure S1b).”
Quote in the paperNot a substantial claim - Findingown data
Upon OSKM induction for 1 week in 55-week-old reprogrammable mice, clear histological changes are observed in the pancreas.
“Upon OSKM induction for 1 week, we observed clear histological changes in the pancreas (Figure S1a).”
Quote in the paperSubstantial claim - Findingown data
Some serum metabolites and biomarkers altered with aging are restored to young levels upon transient reprogramming.
“Finally, some serum metabolites and biomarkers altered with aging were also restored to young levels upon transient reprogramming.”
Quote in the paperSubstantial claim - Findingown data
Using a separate cohort of old mice and a different technique (pyrosequencing), rejuvenation was confirmed in 8 out of 11 tested regions that showed aging-dependent methylation changes.
“Using a separate cohort of old mice and a different technique (pyrosequencing), we confirmed rejuvenation in 8 out of 11 tested regions that showed aging‐dependent methylation changes.”
Quote in the paperSubstantial claim - Findingown data
PCA of aging-DM promoters clearly segregated young from old mice.
“Focusing on these aging‐DM promoters, we performed principal component analyses (PCA) that clearly segregated young from old mice.”
Quote in the paperNot a substantial claim - Findingown data
The majority of OSKM-induced demethylation in the pancreas happened after turning off OSKM expression, during the 2 weeks of recovery period.
“We observed that the majority of OSKM‐induced demethylation in the pancreas happened after turning off OSKM expression, that is, during the 2 weeks of recovery period.”
Quote in the paperNot a substantial claim - Findingown data
The large majority of genes upregulated by OSKM in old mice corresponded to genes with reduced expression upon aging.
“Interestingly, the large majority of genes upregulated by OSKM in old mice (pink dots) corresponded to genes with reduced expression upon aging (Figure 2b, Figure S2a).”
Quote in the paperSubstantial claim - Findingown data
A total of 23 metabolites were significantly changed between young and very old mice when combining two independent serum metabolomics experiments.
“When combining the two independent experiments, a total of 23 metabolites were identified as significantly changed between young and very old mice (Figure S5a,b, Table S10).”
Quote in the paperNot a substantial claim - Findingown data
In spleen, PCA analysis of aging-DM promoters and enhancers did not allow inferring epigenetic rejuvenation of the tissue.
“In the spleen, PCA analysis of aging‐DM promoters and enhancers did not allow to infer an epigenetic rejuvenation of this tissue (Figure S4a,e)”
Quote in the paperNot a substantial claim - Findingown data
Old-OSKM mice increased their levels of collagen-related genes.
“and, remarkably, old‐OSKM mice increased their levels of collagen‐related genes (Figure 2h, Figure S2j).”
Quote in the paperNot a substantial claim - Findingown data
When the same analysis was performed after randomizing the samples, only 44 gene-sets were found.
“When the same analysis was performed after randomizing the samples (i.e., samples were randomly assigned to the three experimental groups: young, old, and old‐OSKM), only 44 gene‐sets were found (see pattern 1 in Table S7).”
Quote in the paperSubstantial claim - Findingown data
Pattern analysis identified a total of 179 gene-sets rejuvenated by OSKM.
“This analysis identified a total of 179 gene‐sets rejuvenated by OSKM (see pattern 1 in Table S6).”
Quote in the paperSubstantial claim - Findingown data
Four aging-associated serum metabolites-4-hydroxyproline, thymine, trimethyl-lysine, and indole-3-propionic acid-were reversed after reprogramming in two cohorts of very old mice.
“Out of these aging‐associated metabolites, 4 were reversed after reprogramming (Figure 5a).”
- Also stated in: § Serum metabolomic profiling reveals systemic benefits · plain
“These metabolites are 4‐hydroxyproline, thymine, trimethyl‐lysine, and indole‐3‐propionic acid”
- Also stated in: § DISCUSSION · plain
“We have detected four serum metabolites that changed with aging and were reversed by OSKM in the two cohorts of old mice: 4‐hydroxyproline, thymine, trimethyl‐lysine, and indole‐3‐propionic acid.”
Quote in the paperSubstantial claim- Rests on an assumption: The serum metabolome is a valid readout of systemic rejuvenation.
- Also stated in: § Serum metabolomic profiling reveals systemic benefits · plain
- Findingreasoning
The total difference in Hsf4 methylation between reprogrammable and non-reprogrammable very old mice was 8%.
“resulting in a total difference of 8% methylation between the reprogrammable and the non‐reprogrammable mice (Figure 4b).”
Quote in the paperNot a substantial claim - Findingown data
In spleen, OSKM transient expression rescued the age-associated decline of seven genes from the Mouse Aging Cell Atlas.
“Interestingly, OSKM transient expression rescued the age‐associated decline of seven of these genes while the senescent marker p16INK4a (Cdkn2a) was unchanged (Figure 4c, Figure S4i).”
Quote in the paperSubstantial claim - Findingown data
In spleen, the senescent marker p16INK4a (Cdkn2a) was unchanged after OSKM.
“Interestingly, OSKM transient expression rescued the age‐associated decline of seven of these genes while the senescent marker p16INK4a (Cdkn2a) was unchanged (Figure 4c, Figure S4i).”
Quote in the paperNot a substantial claim - Findingown data
All these gene-set alterations were ameliorated in old-OSKM mice.
“All these gene‐set alterations were ameliorated in old‐OSKM mice (Figure 2e, Figure S2b‐f).”
Quote in the paperSubstantial claim - Findingown data
In two cohorts of very old OSKM mice, liver levels of p16INK4a, Mcp1, and Cxcl2 did not decline after one cycle of OSKM.
“As expected, all of these were increased with aging; however, their levels did not decline in any of the two cohorts of very old‐OSKM mice (Figure 3c, Figure S3h,i).”
Quote in the paperSubstantial claim - Findingown data
In reprogrammable very old mice, Hsf4 methylation decreased by ~4% over the same 5-week period.
“In contrast, during the same period of time, reprogrammable mice reduced their average methylation levels by ~4%”
- Also stated in: § DISCUSSION · plain
“This was in contrast to mice exposed to one cycle of reprogramming (1 week of OSKM expression followed by 4 weeks of recovery) in which Hsf4 methylation was decreased or maintained.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
Old-OSKM samples behaved like young samples when compared to untreated old control mice.
“Notably, old‐OSKM samples behaved like young samples when compared to untreated old control mice (Figure 2c‐d, Table S5).”
Quote in the paperSubstantial claim - Findingown data
By comparing transcriptome of old versus young pancreata, a list of significantly differentially expressed genes (aging-DEGs, n=217) was identified.
“By comparing the transcriptome of old versus young samples, we identified a list of significantly differentially expressed genes (aging‐DEGs, n = 217) (Table S4).”
Quote in the paperSubstantial claim - Findingown data
PCA of aging-associated DEGs clearly separated old and young samples.
“PCA analysis of these aging‐associated DEGs clearly separated old and young samples as expected.”
Quote in the paperNot a substantial claim - Findingown data
PCA placed old-OSKM profiles between old and young ones, suggesting that transient OSKM activation partially restores aging-related transcriptomic changes.
“Remarkably, PCA placed old‐OSKM profiles between old and young ones, suggesting that transient OSKM activation partially restores aging‐related transcriptomic changes (Figure 2a).”
Quote in the paperSubstantial claim - Findingown data
Five of 15 mRNAs from the Mouse Aging Cell Atlas signature were confirmed to be downregulated in the liver of old mice.
“Five of these genes were confirmed to be downregulated in the liver of our old mice (Figure 3c).”
Quote in the paperNot a substantial claim - Findingown data
The DNA replication gene-set was downregulated in old versus young control mice.
“whereas the DNA replication gene‐set was downregulated (Figure 2d).”
Quote in the paperNot a substantial claim - Findingown data
All five genes recovered young levels of expression in the livers of old-OSKM mice.
“Interestingly, all these five genes recovered young levels of expression in the livers of old‐OSKM mice (Figure 3c).”
Quote in the paperNot a substantial claim - Findingown data
From the total combined number of aging-DM promoters and enhancers in liver (n=108), a substantial fraction (61%) underwent rejuvenation.
“From the total combined number of aging‐DM promoters and enhancers (n = 108), a substantial fraction (61%) underwent rejuvenation (Figure 3b, Figure S3a‐f, Table S8).”
Quote in the paperSubstantial claim - Findingown data
Protein homeostasis was improved in old-OSKM mice.
“Again, this process was improved in old‐OSKM mice (Figure 2g, Figure S2i).”
Quote in the paperSubstantial claim - Findingown data
Genes downregulated by OSKM in old mice were genes with upregulated expression upon aging.
“Conversely, those genes downregulated by OSKM in old mice (blue dots) were genes with upregulated expression upon aging (Figure 2b, Figure S2a).”
Quote in the paperNot a substantial claim - Findingown data
Nrf2 expression was reset to young levels in very old-OSKM spleens.
“Finally, Nrf2 also declined in very old control spleens and its expression was reset to young levels in very old‐OSKM spleens (Figure 4d).”
Quote in the paperNot a substantial claim - Findingown data
In control non-reprogrammable very old mice, Hsf4 methylation increased by 4% over 5 weeks.
“Interestingly, it was possible to detect a 4% increase in Hsf4 methylation in control non‐reprogrammable mice (Figure 4b).”
- Also stated in: § DISCUSSION · plain
“In the case of control mice, we observed an increase in methylation during this period of 5 weeks.”
Quote in the paperNot a substantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
These findings were further validated in an independent cohort of very old mice (100 weeks).
“These findings were further validated in an independent cohort of very old mice (100 weeks) (Figure S3h).”
Quote in the paperNot a substantial claim - Findingown data
The number of γH2AX-positive cells in liver was similar in very old mice with or without one cycle of OSKM.
“We also measured the number of γH2AX‐positive cells, a marker of in vivo senescence, and again the levels in the liver were similar in very old mice with or without 1 cycle of OSKM (Figure S3j).”
Quote in the paperSubstantial claim- Rests on an assumption: γH2AX-positive cells are a marker of in vivo senescence.
- Findingown data
Nrf2 declined in very old control spleens.
“Finally, Nrf2 also declined in very old control spleens and its expression was reset to young levels in very old‐OSKM spleens (Figure 4d).”
Quote in the paperNot a substantial claim - Findingown data
Hsf4 methylation in blood increases linearly with age from ~20% in young mice (~10 weeks) to ~55% in very old mice (~100 weeks).
“First, we measured by pyrosequencing the methylation levels of the Hsf4 region in the blood of mice of different ages, confirming a linear change of large magnitude, from ~20% methylation in young mice (~10 weeks) to ~55% methylation in very old mice (~100 weeks) (Figure 4a).”
- Also stated in: § DISCUSSION · boosted
“Indeed, we found that the degree of methylation of these sites in peripheral blood is tightly linked to the age of the mice.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · boosted
- Findingown data
The mTOR signaling gene-set was upregulated in old versus young control mice.
“As expected, the mTOR signaling gene‐set was upregulated in old versus young control mice (Figure 2c), whereas the DNA replication gene‐set was downregulated (Figure 2d).”
Quote in the paperNot a substantial claim - Findingown data
Serum levels of transaminases (AST/GOT and ALT/GPT) of OSKM mice were significantly lower after 1 week of OSKM activation and 2 weeks of recovery.
“Interestingly, the serum levels of transaminases of OSKM mice were significantly lower after 1 week of OSKM activation and 2 weeks of recovery reflecting an improved liver function (Figure 3e).”
Quote in the paperSubstantial claim - Findingown data
Up to 163 promoter and enhancer regions in spleen showed evidence of rejuvenation according to their average methylation level.
“although up to 163 promoter and enhancer regions showed evidence of rejuvenation according to their average methylation level (Figure S4b‐d,f‐h, Table S9).”
Quote in the paperNot a substantial claim - Findingown data
Lower levels of serum transaminases (ALT/GPT and AST/GOT) were detected after one cycle of reprogramming.
“We also detected lower levels of serum transaminases (ALT/GPT and AST/GOT) after one cycle of reprogramming.”
Quote in the paperNot a substantial claim - Findingcitation
Spleen and liver showed evidence of rejuvenation of a transcriptional signature of aging derived from the Mouse Aging Cell Atlas.
“Nevertheless, spleen and liver did show evidence of rejuvenation of a transcriptional signature of aging derived from the Mouse Aging Cell Atlas (Zhang et al., 2021).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhang et al., 2021
Not checked in the free run.
- Findingown data
No evidence of reduction in senescence markers was observed.
“We did not observe however evidence of reduction in senescence markers.”
Quote in the paperSubstantial claim - Findingnone given
The 2-4 week recovery period was sufficient for full restoration of normal histology in the pancreas.
“This recovery period was sufficient for a full restoration of normal histology in the pancreas.”
Quote in the paperSubstantial claim - Findingown data
About half of the methylation changes observed at the time of switching off OSKM disappeared after 2 weeks.
“Notably, about half of the changes observed at the time of switching off OSKM disappeared after 2 weeks.”
Quote in the paperSubstantial claim - Findingcitation
No associations were established between specific aging-DM regions and mRNA levels of the associated genes.
“We have not been able to establish associations between specific aging‐DM regions and the mRNA levels of the associated genes.”
Quote in the paperNot a substantial claim - Findingown data
One cycle of OSKM (1 week induction and 2 weeks recovery) was sufficient to reset the levels of aging-DEGs to a younger state in pancreas.
“Similar to the methylation data, one cycle of OSKM (1 week of induction and 2 weeks of recovery) was sufficient to reset the levels of aging‐DEGs to a younger state.”
Quote in the paperSubstantial claim - Findingown data
In pancreas, the collagen synthesis gene set was downregulated with aging and rescued by OSKM.
“Notably, our transcriptomic analyses identified collagen synthesis as a gene‐set downregulated with aging and rescued by OSKM in the pancreas (Figure 2h).”
- Also stated in: § DISCUSSION · plain
“Of note, the transcriptional network for collagen synthesis was downregulated with aging and rescued by OSKM in the pancreas.”
Quote in the paperNot a substantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
In spleen and liver, methylation changes in aging-DM regions were not as pronounced as in pancreas, as judged by principal component analyses.
“In the case of the spleen and liver, the methylation changes observed in aging‐DM regions were not as pronounced as in the case of the pancreas, as judged by principal component analyses.”
Quote in the paperNot a substantial claim - Findingown data
The majority of gain-of-methylation events observed after recovery were already present at the time of extinguishing OSKM expression.
“The majority of gain‐of‐methylation events observed after recovery were already present at the time of extinguishing OSKM expression.”
Quote in the paperSubstantial claim - Findingown data
Pyrosequencing measurement of individual aging-methylated CpGs consistently showed more demethylation 4 weeks post-OSKM expression compared to 2 weeks.
“In line with these observations, pyrosequencing measurement of individual aging‐methylated CpGs consistently showed more demethylation 4 weeks post‐OSKM expression compared to 2 weeks.”
Quote in the paperSubstantial claim - Interpretationown data
A single period of OSKM expression can drive epigenetic, transcriptomic, and metabolomic changes toward a younger configuration in multiple tissues and in the serum.
“These observations indicate that a single period of OSKM expression can drive epigenetic, transcriptomic, and metabolomic changes toward a younger configuration in multiple tissues and in the serum.”
Quote in the paperSubstantial claim - Premisecitation
In mice, cycles of OSKM in adult individuals improve their capacity to respond to tissue injury.
“In mice, cycles of OSKM in adult individuals improve their capacity to respond to tissue injury (Chen et al., 2021; Ocampo et al., 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Chen et al., 2021
Not checked in the free run.
- cites Ocampo et al., 2016
Not checked in the free run.
- Interpretationown data
The recovery period is important for the demethylation of aging-DMRs.
“This, together with the RRBS data above (Figure 1e,f), is another indication that the recovery period is important for the demethylation of aging‐DMRs.”
Quote in the paperSubstantial claim - Premisecitation
Reprogrammed cells can subsequently differentiate into somatic cells that are rejuvenated relative to their parental cells.
“Moreover, reprogrammed cells can subsequently differentiate into somatic cells that are now rejuvenated relative to their parental cells (Lapasset et al., 2011; Liu et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Lapasset et al., 2011
Not checked in the free run.
- cites Liu et al., 2011
Not checked in the free run.
- Premisecitation
Reprogramming erases molecular and cellular traits of aging acquired by somatic cells throughout their lifespan.
“This process, generally known as reprogramming, erases molecular and cellular traits of aging acquired by somatic cells throughout their lifespan (Lapasset et al., 2011; Liu et al., 2011; Mahmoudi & Brunet, 2012; Petkovich et al., 2017; Rando & Chang, 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Lapasset et al., 2011
Not checked in the free run.
- cites Liu et al., 2011
Not checked in the free run.
- cites Mahmoudi & Brunet, 2012
Not checked in the free run.
- Premisecitation
Loss of collagens occurs with age in pancreas.
“Finally, loss of collagens occurs with age in pancreas (Riopel & Wang, 2014) and, remarkably, old‐OSKM mice increased their levels of collagen‐related genes (Figure 2h, Figure S2j).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Riopel & Wang, 2014
Not checked in the free run.
- Interpretationown data
Lower serum transaminase levels after OSKM activation and recovery reflect improved liver function.
“Interestingly, the serum levels of transaminases of OSKM mice were significantly lower after 1 week of OSKM activation and 2 weeks of recovery reflecting an improved liver function (Figure 3e).”
Quote in the paperSubstantial claim- Rests on an assumption: Serum transaminase levels are a valid marker of liver function, such that lower levels reflect improved liver function.
- Interpretationown data
A single cycle of OSKM expression has a detectable rejuvenating effect on tissues such as liver, spleen, and blood that do not express high levels of OSKM and do not manifest obvious signs of histological alterations.
“We conclude that a single cycle of OSKM expression has a detectable rejuvenating effect on tissues such as liver, spleen, and blood that do not express high levels of OSKM and do not manifest obvious signs of histological alterations.”
Quote in the paperSubstantial claim- Rests on an assumption: The observed molecular rejuvenation features are not explained by changes in cell composition.
- Rests on an assumption: OSKM transgene expression is mild in liver, spleen, and blood.
- Interpretationown data
A single period of OSKM expression is able to rejuvenate a fraction of the methylation changes that occur with aging in promoters and enhancers.
“We conclude that a single period of OSKM expression is able to rejuvenate a fraction of the methylation changes that occur with aging in promoters and enhancers.”
Quote in the paperSubstantial claim - Interpretationown data
Transient OSKM activation appears to orchestrate a positive reconfiguration of the transcriptome that opposes key hallmarks of aging.
“Overall, transient OSKM activation appears to orchestrate a positive reconfiguration of the transcriptome that opposes key hallmarks of aging.”
Quote in the paperSubstantial claim - Interpretationown data
A single period of transient OSKM in vivo may not be sufficient to rejuvenate the transcriptome of senescent cells present in aged liver.
“These observations suggest that a single period of transient OSKM in vivo may not be sufficient to rejuvenate the transcriptome of the senescent cells present in the aged liver.”
Quote in the paperSubstantial claim- Rests on an assumption: γH2AX-positive cells are a marker of in vivo senescence.
- Premisecitation
Cellular senescence is a potent barrier for reprogramming.
“Cellular senescence is a potent barrier for reprogramming (Haridhasapavalan et al., 2020)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Haridhasapavalan et al., 2020
Not checked in the free run.
- Premisecitation
The Hsf4 intragenic region is differentially methylated during aging in various tissues.
“This particular region has been identified by independent studies as differentially methylated during aging in various tissues (Beerman et al., 2013; Han et al., 2018; Taiwo et al., 2013)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Beerman et al., 2013
Not checked in the free run.
- cites Han et al., 2018
Not checked in the free run.
- cites Taiwo et al., 2013
Not checked in the free run.
- Premisecitation
Serum 4-hydroxyproline is considered to reflect total collagen levels.
“its presence in the serum is considered to reflect total collagen levels (Gabr et al., 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gabr et al., 2017
Not checked in the free run.
- Premisecitation
The Hsf4 region has a large magnitude of change in percentage of methylation from young to old individuals.
“it is extraordinary due to the large magnitude of change in percentage of methylation from young to old individuals (Han et al., 2018).”
- Also stated in: § DISCUSSION · boosted
“A remarkable property of this methylated region is the large magnitude of change in percentage of methylation from young to old individuals (Han et al., 2018).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Han et al., 2018
Not checked in the free run.
- Also stated in: § DISCUSSION · boosted
- Interpretationown data
Transcriptional rejuvenation may be easier to achieve compared to epigenetic rejuvenation.
“It seems, therefore, that transcriptional rejuvenation may be easier to achieve compared to epigenetic rejuvenation.”
Quote in the paperNot a substantial claim- Rests on an assumption: OSKM transgene expression is mild in liver, spleen, and blood.
- Premisecitation
Senescent cells are generally resistant to being reprogrammed.
“Senescent cells are generally resistant to be reprogrammed (Haridhasapavalan et al., 2020).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Haridhasapavalan et al., 2020
Not checked in the free run.
- Interpretationreasoning
A single period of transient OSKM may not be sufficient to rejuvenate the transcriptome of senescent cells present in aged tissues.
“Therefore, a single period of transient OSKM may not be sufficient to rejuvenate the transcriptome of the senescent cells present in aged tissues.”
Quote in the paperSubstantial claim - Interpretationown data
The disappearance of about half of methylation changes after 2 weeks illustrates the existence of unstable changes induced by OSKM.
“This illustrates the existence of unstable changes induced by OSKM and the importance of allowing a recovery period to identify durable changes.”
Quote in the paperSubstantial claim
- May combine two claims. 33
- Classified as probably not a substantial claim. 30
May combine two claims.
Findingown dataRemethylation events were already present at d7 and half of them were preserved during recovery, while the other half were lost.
“In contrast, remethylation events were already present at d7 and half of them were preserved during recovery, while the other half were lost (Figure 1e,f).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWhile pancreas, intestine, and stomach manifest histological changes during OSKM expression, liver and spleen do not present observable histological changes except for signs of extramedullary hematopoiesis in the spleen.
“It is important to mention that while pancreas, intestine, and stomach manifest histological changes during OSKM expression, other tissues, like liver or spleen, do not present observable histological changes except for signs of extramedullary hematopoiesis in the spleen (Figure S1a).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe OSKM cassette is not homogeneously expressed in all cell types; acinar cells of the pancreas rapidly and broadly express SOX2 24h after i.p. injection of doxycycline, but most endocrine cells do not.
“It is also worth mentioning that the OSKM cassette is not homogeneously expressed in all cell types. For example, acinar cells of the pancreas rapidly and broadly express SOX2, 24h after i.p. injection of doxycycline, as detected by immunohistochemistry; however, this was not the case of other cell types of the pancreas, including most endocrine cells (Figure S1d).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong aging-DM enhancers, 17 out of 43 are hypermethylated with aging and demethylated by OSKM, and 8 out of 32 are hypomethylated with aging and remethylated by OSKM.
“We then separated those enhancers that are hypermethylated with aging and demethylated by OSKM (17 out of 43 in total), and those enhancers hypomethylated with aging and remethylated by OSKM (8 out of 32 in total) (Figure 1d, Figure S1j‐k, Table S2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRRBS analysis revealed a total of 93 promoters and 75 enhancers in which methylation changes with aging, and out of them a total of 61 (36%) were reversed toward a younger state by OSKM expression in old mice.
“In summary, RRBS analysis has revealed a total of 93 promoters and 75 enhancers in which methylation changes with aging, and out of them a total of 61 (36%) were reversed toward a younger state by OSKM expression in old mice (Figure 1b,d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmong aging-DM promoters, 19 out of 51 (37%) are hypermethylated with aging and demethylated by OSKM, and 17 out of 42 (40%) are hypomethylated with aging and remethylated by OSKM.
“This yielded a subset of promoters that are hypermethylated with aging and demethylated by OSKM (19 out of 51 in total, 37%), and a subset of promoters that are hypomethylated with aging and remethylated by OSKM (17 out of 42 in total, 40%) (Figure 1b, Figure S1g‐h, Table S1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Hnf1a promoter is among promoters hypermethylated with aging, and OSKM induced a trend of partial demethylation.
“As a notable example, the Hnf1a promoter, a key transcription factor for the development of the pancreas (Lau et al., 2018), was among the promoters hypermethylated with aging and OSKM induced a trend of partial demethylation (Figure 1b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lau et al., 2018
Not checked in the free run.
May combine two claims.
Findingown dataNrf2 and ApoM are downregulated with aging in the liver of very old mice, and this was reverted upon one cycle of OSKM.
“We confirmed that both genes are downregulated with aging in the liver of our very old mice, and this was reverted upon one cycle of OSKM (Figure 3d).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datap21CIP1 (Cdkn1a) expression levels in liver did not change with aging nor with OSKM.
“The levels of p21CIP1 expression (Cdkn1a) were not informative because their levels did not change with aging nor with OSKM (Figure S3h,i).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn mouse liver, p16INK4a, Mcp1, and Cxcl2 levels increased with aging.
“As expected, all of these were increased with aging; however, their levels did not decline in any of the two cohorts of very old‐OSKM mice (Figure 3c, Figure S3h,i).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataIn liver, RRBS covered 5.3% of promoters and 3.5% of enhancers; in spleen, 25% of promoters and 22.4% of enhancers.
“For this, we performed a similar methylation profiling by RRBS analysis in the liver (5.3% of the promoters and 3.5% of the enhancers were covered) and spleen (25% of the promoters and 22.4% of the enhancers were covered), two tissues that modestly upregulate OSKM expression upon doxycycline treatment (Figure S1c).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the pancreas, there is a temporal pattern for OSKM-induced methylation changes (remethylation during OSKM expression and demethylation during the recovery period); this temporal pattern was not evident in the liver.
“In the pancreas, we observed a temporal pattern for OSKM‐induced methylation changes (remethylation during OSKM expression and demethylation during the recovery period). However, this temporal pattern was not evident in the liver (Figure S3g).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPCA of methylation patterns of liver DM promoters and enhancers indicated that old-OSKM mice partially recovered a younger methylation pattern, although separation between experimental groups was not as clear as in pancreas.
“Similar to the pancreas, PCA analysis of the methylation patterns of liver DM promoters and enhancers indicated that old‐OSKM mice partially recovered a younger methylation pattern although the separation between experimental groups was not as clear as in the case of the pancreas (Figure 3a).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGene-sets related to the minichromosome maintenance (MCM) helicase, the DNA replication machinery, mismatch repair, and base excision repair were all reduced in old mice and upregulated to young levels in old-OSKM mice.
“We observed that gene‐sets related to the minichromosome maintenance (MCM) helicase, the DNA replication machinery, mismatch repair, and base excision repair, were all reduced in our old mice and upregulated to young levels in old‐OSKM mice (Figure 2f, Figure S2g‐h).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationGene-sets rejuvenated by OSKM included important aging-related processes, such as mTOR upregulation, insulin increase, reduction of NADPH and pyrimidine synthesis, and decline of mitochondrial processes, such as fatty acid oxidation, tricarboxylic acid cycle, and oxidative phosphorylation.
“More importantly, the gene‐sets rejuvenated by OSKM included important aging‐related processes, such as mTOR upregulation, insulin increase, reduction of NADPH and pyrimidine synthesis, and decline of mitochondrial processes, such as fatty acid oxidation, tricarboxylic acid cycle, and oxidative phosphorylation (Brink et al., 2009; Fontana et al., 2010; López‐Otin et al., 2013) (Figure 2e, Figure S”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Brink et al., 2009
Not checked in the free run.
- cites Fontana et al., 2010
Not checked in the free run.
- cites López‐Otin et al., 2013
Not checked in the free run.
May combine two claims.
Findingown dataTransient OSKM activation reversed well-known transcriptional changes associated with aging, including insulin and mTOR signaling, mitochondrial metabolic processes, and DNA repair.
“Interestingly, transient OSKM activation reversed well‐known transcriptional changes associated to aging. This is the case of insulin and mTOR signaling, mitochondrial metabolic processes, and DNA repair.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOSKM induction caused histologically detectable alterations in the pancreas but not in the spleen or liver.
“This protocol of induction was sufficient to cause histologically detectable alterations in the pancreas, but not in the spleen or liver.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe majority of loss-of-methylation events were absent after OSKM expression and were acquired during the recovery period.
“In contrast, the majority of loss‐of‐methylation events were absent after OSKM expression and, therefore, were acquired during the recovery period.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe simultaneous expression of OCT4, SOX2, KLF4, and MYC (OSKM) in adult differentiated cells can shut off their transcriptional programs for cell identity, activate transcription of pluripotency genes, and establish a new identity equivalent to embryonic stem cells.
“The simultaneous expression of four specific factors, OCT4, SOX2, KLF4, and MYC (OSKM), also known as “Yamanaka factors,” in adult differentiated cells is able to shut off their transcriptional programs for cell identity, activate the transcription of pluripotency genes, and establish a new identity equivalent to embryonic stem cells (Takahashi & Yamanaka, 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Takahashi & Yamanaka, 2006
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationUpon OSKM expression in vivo, a fraction of cells within tissues shut off their cell identity markers and progressively activate the pluripotency program.
“Upon OSKM expression in vivo, a fraction of cells within tissues shut off their cell identity markers and progressively activate the pluripotency program (Abad et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Abad et al., 2013
Not checked in the free run.
May combine two claims.
Interpretationown dataOne week of OSKM expression allows for transient and reversible changes in the histology of the pancreas without achieving pluripotency.
“Therefore, one week of OSKM expression allows for transient and reversible changes in the histology of the pancreas without achieving pluripotency.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRejuvenation of aging-associated DNA methylation occurs progressively during reprogramming, initiated at early stages and continuing until full reprogramming.
“Interestingly, examination of aging‐associated DNA methylation has revealed that rejuvenation of this aging trait occurs progressively during reprogramming, being initiated at the early stages of the process and continuing until full reprogramming (Gill et al., 2021; Olova et al., 2019).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Gill et al., 2021
Not checked in the free run.
- cites Olova et al., 2019
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationOSKM expression in mice recapitulates the process of reprogramming.
“The expression of OSKM in mice recapitulates the process of reprogramming (Abad et al., 2013; Mosteiro et al., 2016; Ohnishi et al., 2014).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Abad et al., 2013
Not checked in the free run.
- cites Mosteiro et al., 2016
Not checked in the free run.
- cites Ohnishi et al., 2014
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationChanges in the epigenome, particularly DNA methylation, are robustly linked to aging.
“Changes in the epigenome, and particularly DNA methylation, are robustly linked to aging (Field et al., 2018; Horvath, 2013; Horvath & Raj, 2018; Stubbs et al., 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Field et al., 2018
Not checked in the free run.
- cites Horvath, 2013
Not checked in the free run.
- cites Horvath & Raj, 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationViral transduction of OSK in the retina of old mice reduces aging-associated DNA methylation and improves vision.
“Also, viral transduction of OSK in the retina of old mice has been shown to reduce aging‐associated DNA methylation and to improve vision (Lu et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lu et al., 2020
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationArid5b encodes a pro-inflammatory RNA-binding protein induced by NF-κB.
“Among the potential target genes in proximity to this enhancer, it is Arid5b that encodes a pro‐inflammatory RNA‐binding protein induced by NF‐κB (Nyati et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nyati et al., 2020
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCycles of OSKM in progeric mice with constitutive DNA damage extend their lifespan significantly.
“Finally, cycles of OSKM in progeric mice with constitutive DNA damage extend significantly their lifespan (Ocampo et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ocampo et al., 2016
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationDNA methylation at specific CpG sites is tightly linked to aging and particularly to biological aging rather than chronological aging.
“Among the various molecular changes associated with aging, DNA methylation at specific CpG sites has turned out to be tightly linked to aging and, particularly, to biological aging rather than chronological aging (Field et al., 2018; Horvath & Raj, 2018).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Field et al., 2018
Not checked in the free run.
- cites Horvath & Raj, 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationReprogrammed tissues present focal areas of dysplasia in which the tissue alters its normal architecture and cells lose differentiation markers.
“Reprogrammed tissues present focal areas of dysplasia in which the tissue alters its normal architecture and cells lose differentiation markers (Abad et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abad et al., 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAt a more advanced stage, tissues present compact areas of undifferentiated cells expressing pluripotency markers, such as NANOG.
“At a more advanced stage, tissues present compact areas of undifferentiated cells expressing pluripotency markers, such as NANOG (Abad et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abad et al., 2013
Not checked in the free run.
May combine two claims.
PremisecitationCycles of short OSKM expression followed by recovery result in rejuvenation, both in vivo and in vitro.
“Remarkably, cycles of short OSKM expression followed by recovery result in rejuvenation, both in vivo and in vitro (Ocampo et al., 2016; Sarkar et al., 2020).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Ocampo et al., 2016
Not checked in the free run.
- cites Sarkar et al., 2020
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn reprogrammable mice, the pancreas is the most susceptible tissue to undergo reprogramming, followed by the intestine and stomach.
“In these mice, the pancreas is the most susceptible tissue to undergo reprogramming, followed by the intestine and stomach (Abad et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abad et al., 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCompletion of reprogramming in vivo manifests by the formation of teratomas, a tumor overgrowth formed by pluripotent cells differentiating into multiple cell lineages.
“The completion of reprogramming in vivo manifests by the formation of teratomas, a tumor overgrowth formed by pluripotent cells differentiating into multiple cell lineages (Abad et al., 2013; Ohnishi et al., 2014).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Abad et al., 2013
Not checked in the free run.
- cites Ohnishi et al., 2014
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe Mouse Aging Cell Atlas aging signature applies to multiple tissues including liver and spleen but not to the pancreas.
“To obtain further insights into the aging‐associated transcriptome of old‐OSKM livers, we examined the top genes of a recently reported aging signature based on the Mouse Aging Cell Atlas (Tabula Muris Consortium, 2020) that applies to multiple tissues including the liver and spleen but not to the pancreas (Zhang et al., 2021).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Tabula Muris Consortium, 2020
Not checked in the free run.
- cites Zhang et al., 2021
Not checked in the free run.
May combine two claims.
Premisecitationp16INK4a (Cdkn2a), Mcp1, and Cxcl2 are known to increase with aging in mouse liver.
“the senescence marker p16INK4a (Cdkn2a) and the senescence‐associated cytokines Mcp1 and Cxcl2, known to increase with aging in mouse liver (Yousefzadeh et al., 2020).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yousefzadeh et al., 2020
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationImpaired protein homeostasis is an important feature of aging.
“Another important feature of aging is impaired protein homeostasis (Powers et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Powers et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFoxa3 serves as a pioneer transcription factor for the maintenance of liver-specific transcription.
“This included Foxa3 which serves as a pioneer transcription factor for the maintenance of liver‐specific transcription (Iwafuchi‐Doi et al., 2016) (Figure 3b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Iwafuchi‐Doi et al., 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSenescent cells increase with aging and may account for up to 17% of hepatocytes in extremely old mice (~3 years of age).
“Senescent cells increase with aging and may account for up to 17% of the hepatocytes in extremely old mice (~3 years of age) (Wang et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wang et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSerum 4-hydroxyproline declines with aging.
“Serum 4‐hydroxyproline has been reported to decline with aging (Seo et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Seo et al., 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation4-hydroxyproline amounts to 14% of all amino acids in collagen.
“This modified amino acid amounts to 14% of all the amino acids in collagen”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gabr et al., 2017
Not checked in the free run.
May combine two claims.
Interpretationown dataA single cycle of transient OSKM expression in naturally aged mice can elicit epigenetic, transcriptomic, and serum metabolomic changes that partially restore younger patterns, constituting stable reversion of molecular features of natural aging.
“In this work, we report that a single cycle of transient OSKM expression in naturally aged mice can elicit epigenetic, transcriptomic, and serum metabolomic changes that partially restore younger patterns.”
- Also stated in: § DISCUSSION · plain
“In this work, we report stable reversion of molecular features of natural aging by a single cycle of OSKM expression. The observed rejuvenation features include DNA methylation, transcription, and serum metabolites.”
Quote in the paperSubstantial claim- Rests on an assumption: The serum metabolome is a valid readout of systemic rejuvenation.
- Rests on an assumption: The observed molecular rejuvenation features are not explained by changes in cell composition.
- Rests on an assumption: OSKM transgene expression is mild in liver, spleen, and blood.
- Also stated in: § DISCUSSION · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLack of association between aging-DM regions and transcription is a general finding made by multiple researchers studying aging-DM regions.
“This lack of association between aging‐DM regions and transcription is, however, a general finding made by multiple researchers studying aging‐DM regions (see detailed discussion in (Horvath & Raj, 2018)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Horvath & Raj, 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe strategy of correcting gene-set scores by fitting a linear model with group condition and using a global signature is useful to alleviate systematic biases due to gene-correlation structure and to adjust for the expectation under gene randomization.
“This strategy has proven to be useful to alleviate systematic biases due to the gene‐correlation structure present in the data, and to adjust by the expectation under gene randomization, that is, the association expected for a signature whose genes have been chosen at random (Efron & Tibshirani, 2007; Mestres et al., 2018).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Efron & Tibshirani, 2007
Not checked in the free run.
- cites Mestres et al., 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther tissues also contribute to the total levels of serum transaminases.
“However, there are growing evidences suggesting that other tissues also contribute to the total levels of serum transaminases (Kobayashi et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kobayashi et al., 2020
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationROAST, a rotation-based approach implemented in limma, is especially suitable for small-size experiments.
“Pathway enrichment analysis for group comparisons of gene expression was performed using a modification of ROAST (Wu et al., 2010), a rotation‐based approach implemented in the R package limma (Ritchie et al., 2015) that is especially suitable for small size experiments and is based on limma differential expression.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Wu et al., 2010
Not checked in the free run.
- cites Ritchie et al., 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThe molecular manifestations of rejuvenation likely reflect a complex mixture of direct and indirect effects on multiple tissues.
“These molecular manifestations of rejuvenation likely reflect a complex mixture of direct and indirect effects on multiple tissues.”
Quote in the paperNot a substantial claim- Rests on an assumption: The observed molecular rejuvenation features are not explained by changes in cell composition.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe production of NETs by stimulated neutrophils declines with aging.
“Interestingly, the production of NETs by stimulated neutrophils declines with aging (Hazeldine & Lord, 2018)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hazeldine & Lord, 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAging-DM regions often occur in bivalent, silent promoters where gain of methylation does not impact the already silent transcriptional state.
“For example, aging‐DM regions often occur in bivalent, silent, promoters where gain of methylation does not impact the already silent transcriptional state (Horvath & Raj, 2018).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Horvath & Raj, 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenMice were randomly allocated to experimental groups, except the very old (100 weeks) cohort, which was not randomized and was distributed according to predetermined genotype.
“Mice were randomly allocated to their experimental groups, except from the cohort of very old mice (100 weeks) which were distributed according to their pre‐determined type (mouse genotype), and therefore, there was no randomization.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenDNA methylation patterns were validated by bisulfite pyrosequencing.
“DNA methylation patterns were validated by bisulfite pyrosequencing.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenQuantitative PCR data were obtained from independent biological replicates, with n values corresponding to the number of mice and technical PCR replicates not counted in the n value.
“Quantitative PCR data were obtained from independent biological replicates (n values correspond to the number of mice; technical replicates of PCR were not considered in the n value).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThymine has been found to extend lifespan in C. elegans.
“Thymine has been found to extend lifespan in C. elegans (Wan et al., 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wan et al., 2019
Not checked in the free run.
The paper relies on this without support.
Interruption of reprogramming at its early stages is fully reversible and does not result in a detectable risk of teratoma.
“Of note, interruption of the process of reprogramming at its early stages is fully reversible and does not result in a detectable risk of teratoma.”
The paper relies on this without support.
Serum transaminase levels are a valid marker of liver function, such that lower levels reflect improved liver function.
“reflecting an improved liver function (Figure 3e).”
The paper relies on this without support.
The serum metabolome is a valid readout of systemic rejuvenation.
“As a readout of systemic rejuvenation, we focused on serum metabolites.”
The paper relies on this without support.
The observed molecular rejuvenation features are not explained by changes in cell composition.
“This may also result in changes in cell composition that have not been addressed in this work.”
The paper relies on this without support.
γH2AX-positive cells are a marker of in vivo senescence.
“We also measured the number of γH2AX‐positive cells, a marker of in vivo senescence”
The paper relies on this without support.
OSKM transgene expression is mild in liver, spleen, and blood.
“This is not entirely surprising if we consider the mild expression of the OSKM transgene in these tissues.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Epigenetic profile assessed by methylation clocks was rejuvenated by cyclic OSKM induction in several tissues, correlated with improved function.
“Further studies showed that the epigenetic profile assessed by epigenetic methylation clocks (Browder et al., 2022; Chondronasiou et al., 2022; Horvath, 2013; Horvath and Raj, 2018) was rejuvenated by cyclic OSKM induction in several tissues, correlated with their improved function”
From Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice (2024) · cites this paper as Chondronasiou et al., 2022
The Results sections on the pancreas and tissues with low reprogramming report younger DNA-methylation patterns in several tissues after OSKM expression; the latter also reports a physiological readout interpreted as improved liver function (page numbers unavailable). But this study examined a single cycle of OSKM, assessed aging-associated methylation changes rather than rejuvenation by epigenetic clocks, and did not establish a correlation between methylation changes and improved tissue function. (LLM, conf=0.88)
Experimental — accuracy not yet measuredReprogramming factors rejuvenate DNA methylation and transcriptome in several organs of old mice (pancreas, liver, spleen and blood).
“Studies so far have shown that reprogramming factors ‘reset’ chromatin modifications in old cells228 and rejuvenate the DNA methylation and transcriptome in several organs of old mice (pancreas, liver, spleen and blood)233.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [233]
Cites
Fitting Linear Mixed-Effects Models Using <b>lme4</b>
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835 · see citing works
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · see citing works
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works
<b>lmerTest</b> Package: Tests in Linear Mixed Effects Models
Kuznetsova, A., Brockhoff, P. B., & Christensen, R. H. B. (2017) · Journal of Statistical Software · doi:10.18637/jss.v082.i13 · Cited by 24,346 · see citing works
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · see citing works
Self-citationSimultaneous Inference in General Parametric Models
Hothorn, T., Bretz, F., & Westfall, P. H. (2008) · Biometrical Journal · doi:10.1002/bimj.200810425 · Cited by 13,950 · see citing works
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807 · see citing works
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075 · see citing works
The Gene Ontology Resource: 20 years and still GOing strong
The Gene Ontology Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1055 · Cited by 4,747 · see citing works
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Durinck, S., Spellman, P. T., Birney, E., & Huber, W. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,081 · see citing works
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
Horvath, S., & Raj, K. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0004-3 · Cited by 3,095 · see citing works
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023 · see citing works
A comparative encyclopedia of DNA elements in the mouse genome
Yue, F., Cheng, Y., Breschi, A., Vierstra, J., Wu, W., Ryba, T., Sandstrom, R., Ma, Z., Davis, C., Pope, B. D., et al. (2014) · Nature · doi:10.1038/nature13992 · Cited by 1,781 · see citing works
A single-cell transcriptomic atlas characterizes ageing tissues in the mouse
The Tabula Muris Consortium, Almanzar, N., Antony, J., Baghel, A. S., Bakerman, I., Bansal, I., Barres, B. A., Beachy, P. A., Berdnik, D., Bilen, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2496-1 · Cited by 1,247 · see citing works
Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis
Meissner, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki901 · Cited by 1,203 · see citing works
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., & Balch, W. E. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.114844 · Cited by 1,149 · see citing works
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988 · see citing works
Reprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820 · see citing works
Analyzing gene expression data in terms of gene sets: methodological issues
Goeman, J. J., & Bühlmann, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm051 · Cited by 795 · see citing works
On testing the significance of sets of genes
Efron, B., & Tibshirani, R. J. (2007) · The Annals of Applied Statistics · doi:10.1214/07-aoas101 · Cited by 785 · see citing works
DNA damage response and cellular senescence in tissues of aging mice
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin‐Ruiz, C., & Von Zglinicki, T. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00481.x · Cited by 696 · see citing works
DNA Methylation Clocks in Aging: Categories, Causes, and Consequences
Field, A. E., Robertson, N., Wang, T., Havas, A. P., Ideker, T., & Adams, P. D. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.008 · Cited by 622 · see citing works
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589 · see citing works
Self-citationRecapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome
Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., Panopoulos, A. D., Suzuki, K., Kurian, L., Walsh, C., et al. (2011) · Nature · doi:10.1038/nature09879 · Cited by 575 · see citing works
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Aït-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J., et al. (2011) · Genes & Development · doi:10.1101/gad.173922.111 · Cited by 570 · see citing works
ROAST: rotation gene set tests for complex microarray experiments
Wu, D., Lim, E., Vaillant, F., Asselin-Labat, M.-L., Visvader, J. E., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq401 · Cited by 560 · see citing works
Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., et al. (2013) · Nature · doi:10.1038/nature12586 · Cited by 547 · see citing works
Self-citationAging, Rejuvenation, and Epigenetic Reprogramming: Resetting the Aging Clock
Rando, T. A., & Chang, H. Y. (2012) · Cell · doi:10.1016/j.cell.2012.01.003 · Cited by 520 · see citing works
Beerman, I., Bock, C., Garrison, B. S., Smith, Z. D., Gu, H., Meissner, A., & Rossi, D. J. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.017 · Cited by 485 · see citing works
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460 · see citing works
Redox regulation by NRF2 in aging and disease
Schmidlin, C. J., Dodson, M. B., Madhavan, L., & Zhang, D. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.016 · Cited by 441 · see citing works
Changes in DNA repair during aging
Gorbunova, V., Seluanov, A., Mao, Z., & Hine, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm756 · Cited by 405 · see citing works
Using DNA methylation profiling to evaluate biological age and longevity interventions
Petkovich, D. A., Podolskiy, D. I., Lobanov, A. V., Lee, S.-G., Miller, R. A., & Gladyshev, V. N. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.016 · Cited by 398 · see citing works
Iwafuchi-Doi, M., Donahue, G., Kakumanu, A., Watts, J. A., Mahony, S., Pugh, B. F., Lee, D., Kaestner, K. H., & Zaret, K. S. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.001 · Cited by 390 · see citing works
The role of DNA damage and repair in aging through the prism of Koch-like criteria
Moskalev, A. A., Shaposhnikov, M. V., Plyusnina, E. N., Zhavoronkov, A., Budovsky, A., Yanai, H., & Fraifeld, V. E. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.001 · Cited by 387 · see citing works
Multi-tissue DNA methylation age predictor in mouse
BI Ageing Clock Team, Stubbs, T. M., Bonder, M. J., Stark, A.-K., Krueger, F., von Meyenn, F., Stegle, O., & Reik, W. (2017) · Genome Biology · doi:10.1186/s13059-017-1203-5 · Cited by 384 · see citing works
Self-citationTissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice
Yousefzadeh, M. J., Zhao, J., Bukata, C., Wade, E. A., McGowan, S. J., Angelini, L. A., Bank, M. P., Gurkar, A. U., McGuckian, C. A., Calubag, M. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13094 · Cited by 331 · see citing works
Sarkar, T. J., Quarta, M., Mukherjee, S., Colville, A., Paine, P., Doan, L., Tran, C. M., Chu, C. R., Horvath, S., Qi, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15174-3 · Cited by 308 · see citing works
Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice
Chen, Y., Lüttmann, F. F., Schoger, E., Schöler, H. R., Zelarayán, L. C., Kim, K.-P., Haigh, J. J., Kim, J., & Braun, T. (2021) · Science · doi:10.1126/science.abg5159 · Cited by 297 · see citing works
The molecular functions of hepatocyte nuclear factors – In and beyond the liver
Lau, H. H., Ng, N. H. J., Loo, L. S. W., Jasmen, J. B., & Teo, A. K. K. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.026 · Cited by 250 · see citing works
Multi-omic rejuvenation of human cells by maturation phase transient reprogramming
Gill, D., Parry, A., Santos, F., Okkenhaug, H., Todd, C. D., Hernando-Herraez, I., Stubbs, T. M., Milagre, I., & Reik, W. (2022) · eLife · doi:10.7554/elife.71624 · Cited by 185 · see citing works
Self-citationPartial reprogramming induces a steady decline in epigenetic age before loss of somatic identity
Olova, N. N., Simpson, D. J., Marioni, R. E., & Chandra, T. (2018) · Aging Cell · doi:10.1111/acel.12877 · Cited by 179 · see citing works
Aging and reprogramming: a two-way street
Mahmoudi, S., & Brunet, A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.10.004 · Cited by 171 · see citing works
Mouse aging cell atlas analysis reveals global and cell type-specific aging signatures
Zhang, M. J., Pisco, A. O., Darmanis, S., & Zou, J. (2021) · eLife · doi:10.7554/elife.62293 · Cited by 114 · see citing works
Carlson, M. (2017) · NCI BioConductor · doi:10.18129/b9.bioc.org.hs.eg.db · Cited by 90 · see citing works
Arid5a, an RNA-Binding Protein in Immune Regulation: RNA Stability, Inflammation, and Autoimmunity
Nyati, K. K., Zaman, M. M.-U., Sharma, P., & Kishimoto, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.004 · Cited by 83 · see citing works
Brink, T. C., Demetrius, L., Lehrach, H. R., & Adjaye, J. (2008) · Biogerontology · doi:10.1007/s10522-008-9197-8 · Cited by 78 · see citing works
In vivo reprogramming drives Kras-induced cancer development
Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., Kabata, M., Sakurai, S., Kuze, B., Woltjen, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04449-5 · Cited by 76 · see citing works
Specificity of transaminase activities in the prediction of drug-induced hepatotoxicity
Kobayashi, A., Suzuki, Y., & Sugai, S. (2020) · The Journal of Toxicological Sciences · doi:10.2131/jts.45.515 · Cited by 68 · see citing works
Collagen matrix support of pancreatic islet survival and function
Riopel, M. (2014) · Frontiers in bioscience · doi:10.2741/4196 · Cited by 67 · see citing works
An Insight into Reprogramming Barriers to iPSC Generation
Haridhasapavalan, K. K., Raina, K., Dey, C., Adhikari, P., & Thummer, R. P. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09931-1 · Cited by 67 · see citing works
The metabolomic signature of extreme longevity: naked mole rats versus mice
Viltard, M., Durand, S., Pérez-Lanzón, M., Aprahamian, F., Lefevre, D., Leroy, C., Madeo, F., Kroemer, G., & Friedlander, G. (2019) · Aging · doi:10.18632/aging.102116 · Cited by 62 · see citing works
Self-citationEpigenetic age-predictor for mice based on three CpG sites
Han, Y., Eipel, M., Franzen, J., Sakk, V., Dethmers-Ausema, B., Yndriago, L., Izeta, A., de Haan, G., Geiger, H., & Wagner, W. (2018) · eLife · doi:10.7554/elife.37462 · Cited by 61 · see citing works
Altered MCM Protein Levels and Autophagic Flux in Aged and Systemic Sclerosis Dermal Fibroblasts
Dumit, V. I., Küttner, V., Käppler, J., Piera-Velázquez, S., Jiménez, S. A., Bruckner‐Tuderman, L., Uitto, J., & Dengjel, J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.69 · Cited by 60 · see citing works
Ding, B., Yang, D., Swendeman, S. L., Christoffersen, C., Nielsen, L. B., Friedman, S. L., Powell, C. A., Hla, T., & Cao, Z. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.024 · Cited by 51 · see citing works
Guo, Y., Peng, Y., Gao, D., et al. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0412-9 · Cited by 46 · see citing works
Quantifying alternative splicing from paired-end RNA-sequencing data
Rossell, D., Attolini, C. S., Kroiss, M., & Stöcker, A. (2014) · The Annals of Applied Statistics · doi:10.1214/13-aoas687 · Cited by 44 · see citing works
A Unified Approach for Simultaneous Gene Clustering and Differential Expression Identification
Yuan, M., & Kendziorski, C. M. (2006) · Biometrics · doi:10.1111/j.1541-0420.2006.00611.x · Cited by 44 · see citing works
DNA methylation analysis of murine hematopoietic side population cells during aging
Taiwo, O., Wilson, G. A., Emmett, W., Morris, T. J., Bonnet, D. A., Schuster, E. F., Adejumo, T., Beck, S., & Pearce, D. J. (2013) · Epigenetics · doi:10.4161/epi.26017 · Cited by 43 · see citing works
Wan, Q.-L., Meng, X., Fu, X., Chen, B., Yang, J., Yang, H., & Zhou, Q. (2019) · Aging · doi:10.18632/aging.102033 · Cited by 37 · see citing works
Metabolomic study of aging in mouse plasma by gas chromatography–mass spectrometry
Seo, C., Hwang, Y.-H., Kim, Y., Joo, B. S., Yee, S., Kim, C. M., & Paik, M. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.04.052 · Cited by 35 · see citing works
Ichinohe, N., Ishii, M., Tanimizu, N., Kon, J., Yoshioka, Y., Ochiya, T., Mizuguchi, T., Hirata, K., & Mitaka, T. (2016) · Stem Cells · doi:10.1002/stem.2548 · Cited by 28 · see citing works
Multi-omic rejuvenation of human cells by maturation phase transient reprogrammingPreprint
Gill, D., Parry, A., Santos, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.15.426786 · Cited by 25 · see citing works
Self-citationHydroxyproline as a Biomarker in Liver Disease
Gabr, S. A., Alghadir, A. H., Sherif, Y. E.-S., et al. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_26 · Cited by 17 · see citing works
GaGa: A parsimonious and flexible model for differential expression analysis
Rossell, D. (2009) · The Annals of Applied Statistics · doi:10.1214/09-aoas244 · Cited by 16 · see citing works
Caballé, A., Berenguer, A., & Attolini, C. S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/360495 · Cited by 5 · see citing works
Mouse Aging Cell Atlas Analysis Reveals Global and Cell Type Specific Aging Signatures Revision 1Preprint
Zhang, M. J., Pisco, A. O., Darmanis, S., & Zou, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.23.887604 · Cited by 4 · see citing works
The Impact of Age on Neutrophil Extracellular Trap Formation
Hazeldine, J., & Lord, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_102-1 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1126/SCIENCE.ABG5159/SUPPL_FILE/SCIENCE.ABG5159_MOVIES_S1_TO_S8.ZIP · DOI
Cited by
Sorted by citations
Hallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · see citing works
Self-citationAgeing and rejuvenation of tissue stem cells and their niches
Brunet, A., Goodell, M. A., & Rando, T. A. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00510-w · Cited by 407 · see citing works
The Information Theory of Aging
Lu, Y. R., Tian, X., & Sinclair, D. A. (2023) · Nature Aging · doi:10.1038/s43587-023-00527-6 · Cited by 141 · see citing works
Macip, C. C., Hasan, R., Hoznek, V., Kim, J., Metzger, L. E., Sethna, S., & Davidsohn, N. (2023) · doi:10.1101/2023.01.04.522507 · Cited by 95 · see citing works
Macip, C. C., Hasan, R., Hoznek, V., Kim, J., Lu, Y. R., Metzger, L. E., Sethna, S., & Davidsohn, N. (2024) · Cellular Reprogramming · doi:10.1089/cell.2023.0072 · Cited by 95 · see citing works
Vitamin B12 is a limiting factor for induced cellular plasticity and tissue repair
Kovatcheva, M., Melendez, E., Chondronasiou, D., Pietrocola, F., Bernad, R., Caballe, A., Junza, A., Capellades, J., Holguín-Horcajo, A., Prats, N., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00916-6 · Cited by 58 · see citing works
Self-citationPaine, P. T., Rechsteiner, C., Morandini, F., Desdín-Micó, G., Mrabti, C., Parras, A., Haghani, A., Brooke, R., Horvath, S., Seluanov, A., et al. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1323194 · Cited by 13 · see citing works
- Authors
- Chondronasiou, D., Gill, D., Mosteiro, L., Urdinguio, R. G., Berenguer‐Llergo, A., Aguilera, M., Durand, S., Aprahamian, F., Nirmalathasan, N., Abad, M., Martin‐Herranz, D. E., Stephan‐Otto Attolini, C., Prats, N., Kroemer, G., Fraga, M. F., Reik, W., & Serrano, M.
- Affiliations
- Institute for Research in Biomedicine (ES)
- Babraham Institute (GB)
- Genentech (US)
- Cancer Epigenetics and Nanomedicine Laboratory Nanomaterials and Nanotechnology Research Center (CINN CSIC) Oviedo Spain
- Institute for Research in Biomedicine (IRB Barcelona) Barcelona Institute of Science and Technology (BIST) Barcelona Spain
- Metabolomics and Cell Biology Platforms Institut Gustave Roussy Villejuif France
- Inserm (FR)
- Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain
- Chronomics Ltd Cambridge UK
- Karolinska University Hospital (SE)
- Consejo Superior de Investigaciones Científicas (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2022-03
- Volume
- 21
- Issue
- 3
- Pages
- e13578-e13578
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- PMC
- PMC8920440
- OpenAlex
- W4214855865
- Cited by
- 133
- References
- 72
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 35 · 2023: 32 · 2022: 15 · 2021: 1
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Aging Cell (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Apollo (cc-by)
- Funders
- H2020 European Research Council (ERC‐2014‐AdG/669622)
- Fundación Científica Asociación Española Contra el Cáncer (PROYE18061FERN)
- Ministerio de Ciencia e Innovación (SAF2013‐48256‐R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- OSKM, aging reversal, DNA methylation, epigenetic reprogramming, transcriptome, serum metabolites, aging biomarkers, pancreas, liver, spleen, serum, tissue rejuvenation
- MeSH terms
- Epigenome, Animals, Cell Differentiation, Rejuvenation, DNA Methylation, Mice, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review